Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 13, 2019	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-19-001261.pdf
Feb 11, 2019	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000932471-19-005508.pdf
Feb 07, 2019	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001532176-19-000009.pdf 0001532176-19-000009.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 06, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0001532176-19-000005.pdf 0001532176-19-000005.xls
Feb 06, 2019	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000215457-19-005675.pdf
Jan 18, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000008.pdf 0001237899-19-000008.xls
Jan 11, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000007.pdf 0001237899-19-000007.xls
Jan 07, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-19-000977.pdf 0001104659-19-000977.xls
Jan 04, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000001.pdf 0001237899-19-000001.xls
Jan 04, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-19-000004.pdf 0001708138-19-000004.xls

Data provided by Kaleidoscope.

Investors & Media